Up a level |
Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ et al (show 28 more authors)
(2019)
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial (vol 29, pg 1843, 2018).
ANNALS OF ONCOLOGY, 30 (12).
pp. 2013-2014.
Singh, D, Ganesan, AP, Panwar, B, Eschweiler, S, Hanley, CJ ORCID: 0000-0003-3816-7220, Madrigal, A, Ramírez-Suástegui, C, Wang, A, Clarke, J, Wood, O et al (show 13 more authors)
(2020)
CD4<sup>+</sup> follicular helper-like T cells are key players in anti-tumor immunity.
Journal of Clinical Investigation.